[1]
|
Semenza, G.L. (2011) Oxygen Sensing, Homeostasis, and Disease. The New England Journal of Medicine, 365, 537-47. https://doi.org/10.1056/NEJMra1011165
|
[2]
|
Topalian, S.L., et al. (2012) Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer. The New England Journal of Medicine, 366, 2443-2454.
|
[3]
|
Herbst, R.S., et al. (2014) Predictive Correlates of Response to the Anti-PD-L1 Antibody MPDL3280A in Cancer Patients. Nature, 515, 563-567. https://doi.org/10.1038/nature14011
|
[4]
|
Gao, Q., et al. (2009) Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma. Clinical Cancer Research, 15, 971-979.
https://doi.org/10.1158/1078-0432.CCR-08-1608
|
[5]
|
Calderaro, J., et al. (2016) Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma: Relationship with Clinical and Pathological Features. Hepatology, 64, 2038-2046.
|
[6]
|
DeLisser, H., et al. (2010) Vascular Endothelial Platelet Endothelial Cell Adhesion Molecule 1 (PECAM-1) Regulates Advanced Metastatic Progression. Proceedings of the National Academy of Sciences of the United States of America, 107, 18616-18621. https://doi.org/10.1073/pnas.1004654107
|
[7]
|
(2020) Erratum: Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 70, 313. https://doi.org/10.3322/caac.21609
|
[8]
|
王奕鸿, 方永平, 李坤平. 手术治疗余肝体积不足肝癌的研究进展[J]. 临床医学研究与实践, 2021(6): 190-192.
|
[9]
|
Tanaka, M., et al. (2011) Hepatitis B and C Virus Infection and Hepatocellular Carcinoma in China: A Review of Epidemiology and Control Measures. Journal of Epidemiology, 21, 401-416. https://doi.org/10.2188/jea.JE20100190
|
[10]
|
Postow, M.A., Callahan, M.K. and Wolchok, J.D. (2015) Immune Checkpoint Blockade in Cancer Therapy. Journal of Clinical Oncology, 33, 1974-1982. https://doi.org/10.1200/JCO.2014.59.4358
|
[11]
|
Cockman, M.E., et al. (2000) Hypoxia Inducible Factor-Alpha Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor Protein. Journal of Biological Chemistry, 275, 25733-25741.
https://doi.org/10.1074/jbc.M002740200
|
[12]
|
Jaakkola, P., et al. (2001) Targeting of HIF-alpha to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation. Science, 292, 468-472. https://doi.org/10.1126/science.1059796
|
[13]
|
Maxwell, P.H., et al. (1999) The Tumour Suppressor Protein VHL Targets Hypoxia-Inducible Factors for Oxygen-Dependent Proteolysis. Nature, 399, 271-275. https://doi.org/10.1038/20459
|
[14]
|
Greer, S.N., Metcalf, J.L., Wang, Y. and Ohh, M. (2012) The Updated Biology of Hypoxia-Inducible Factor. The EMBO Journal, 31, 2448-2460. https://doi.org/10.1038/emboj.2012.125
|
[15]
|
Shen, C. and Kaelin Jr., W.G. (2013) The VHL/HIF Axis in Clear Cell Renal Carcinoma. Seminars in Cancer Biology, 23, 18-25. https://doi.org/10.1016/j.semcancer.2012.06.001
|
[16]
|
Xia, X., et al. (2009) Integrative Analysis of HIF Binding and Transactivation Reveals Its Role in Maintaining Histone Methylation Homeostasis. Proceedings of the National Academy of Sciences of the United States of America, 106, 4260-4265. https://doi.org/10.1073/pnas.0810067106
|
[17]
|
Thienpont, B., et al. (2016) Tumour Hypoxia Causes DNA Hypermethylation by Reducing TET Activity. Nature, 537, 63-68. https://doi.org/10.1038/nature19081
|
[18]
|
Chen, C., et al. (2001) Regulation of glut1 mRNA by Hypoxia-Inducible Factor-1. Interaction between H-ras and Hypoxia. Journal of Biological Chemistry, 276, 9519-9525. https://doi.org/10.1074/jbc.M010144200
|
[19]
|
Amann, T., et al. (2009) GLUT1 Expression Is Increased in Hepatocellular Carcinoma and Promotes Tumorigenesis. The American Journal of Pathology, 174, 1544-1552. https://doi.org/10.2353/ajpath.2009.080596
|
[20]
|
Gwak, G.Y., et al. (2005) Hypoxia Stimulates Proliferation of Human Hepatoma Cells through the Induction of Hexokinase II Expression. Journal of Hepatology, 42, 358-364. https://doi.org/10.1016/j.jhep.2004.11.020
|
[21]
|
Semenza, G.L., et al. (1996) Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-Inducible Factor 1. Journal of Biological Chemistry, 271, 32529-32537. https://doi.org/10.1074/jbc.271.51.32529
|
[22]
|
Kim, J.W., et al. (2006) HIF-1-Mediated Expression of Pyruvate Dehydrogenase Kinase: A Metabolic Switch Required for Cellular Adaptation to Hypoxia. Cell Metabolism, 3, 177-185. https://doi.org/10.1016/j.cmet.2006.02.002
|
[23]
|
Lai, R.K., et al. (2016) NDUFA4L2 Fine-Tunes Oxidative Stress in Hepatocellular Carcinoma. Clinical Cancer Research, 22, 3105-3117. https://doi.org/10.1158/1078-0432.CCR-15-1987
|
[24]
|
Masson, N. and Ratcliffe, P.J. (2014) Hypoxia Signaling Pathways in Cancer Metabolism: The Importance of Co-Selecting Interconnected Physiological Pathways. Cancer & Metabolism, 2, 3.
https://doi.org/10.1186/2049-3002-2-3
|
[25]
|
Zhang, L., et al. (2013) Hypoxia Induces Epithelial-Mesenchymal Transition via Activation of SNAI1 by Hypoxia-Inducible Factor-1α in Hepatocellular Carcinoma. BMC Cancer, 13, 108. https://doi.org/10.1186/1471-2407-13-108
|
[26]
|
Copple, B.L. (2010) Hypoxia Stimulates Hepatocyte Epithelial to Mesenchymal Transition by Hypoxia-Inducible Factor and Transforming Growth Factor-Beta-Dependent Mechanisms. Liver International, 30, 669-682.
https://doi.org/10.1111/j.1478-3231.2010.02205.x
|
[27]
|
Tabatabai, G., et al. (2006) Irradiation and Hypoxia Promote Homing of Haematopoietic Progenitor Cells towards Gliomas by TGF-Beta-Dependent HIF-1alpha-Mediated Induction of CXCL12. Brain, 129, 2426-2435.
https://doi.org/10.1093/brain/awl173
|
[28]
|
McMahon, S., et al. (2006) Transforming Growth Factor beta1 Induces Hypoxia-Inducible Factor-1 Stabilization through Selective Inhibition of PHD2 Expression. Journal of Biological Chemistry, 281, 24171-24181.
https://doi.org/10.1074/jbc.M604507200
|
[29]
|
Sahlgren, C., et al. (2008) Notch Signaling Mediates Hypoxia-Induced Tumor Cell Migration and Invasion. Proceedings of the National Academy of Sciences of the United States of America, 105, 6392-6397.
https://doi.org/10.1073/pnas.0802047105
|
[30]
|
Tirpe, A.A., et al. (2019) Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes. International Journal of Molecular Sciences, 20, 6140. https://doi.org/10.3390/ijms20246140
|
[31]
|
Zhang, L., Liu, H.J., Mu, X.D., Cui, J.L. and Peng, Z.G. (2017) Dysregulation of Fra1 Expression by Wnt/β-Catenin Signalling Promotes Glioma Aggressiveness through Epithelial-Mesenchymal Transition. Bioscience Reports, 37, BSR20160643. https://doi.org/10.1042/BSR20160643
|
[32]
|
Chen, Z., et al. (2018) MiR-3662 Suppresses Hepatocellular Carcinoma Growth through Inhibition of HIF-1α-Mediated Warburg Effect. Cell Death & Disease, 9, 549. https://doi.org/10.1038/s41419-018-0616-8
|
[33]
|
Li, B., et al. (2017) Mutual Regulation of MiR-199a-5p and HIF-1α Modulates the Warburg Effect in Hepatocellular Carcinoma. Journal of Cancer, 8, 940-949. https://doi.org/10.7150/jca.17496
|
[34]
|
Zhang, L.F., et al. (2015) Suppression of miR-199a Maturation by HuR Is Crucial for Hypoxia-Induced Glycolytic Switch in Hepatocellular Carcinoma. The EMBO Journal, 34, 2671-2685. https://doi.org/10.15252/embj.201591803
|
[35]
|
Jiang, Y., et al. (2015) Temporal Regulation of HIF-1 and NF-κB in Hypoxic Hepatocarcinoma Cells. Oncotarget, 6, 9409-9419. https://doi.org/10.18632/oncotarget.3352
|
[36]
|
Xu, H., et al. (2014) MiR-338-3p Inhibits Hepatocarcinoma Cells and Sensitizes These Cells to Sorafenib by Targeting Hypoxia-Induced Factor 1α. PLoS ONE, 9, e115565. https://doi.org/10.1371/journal.pone.0115565
|
[37]
|
Csak, T., et al. (2015) microRNA-122 Regulates Hypoxia-Inducible Factor-1 and Vimentin in Hepatocytes and Correlates with Fibrosis in Diet-Induced Steatohepatitis. Liver International, 35, 532-541. https://doi.org/10.1111/liv.12633
|
[38]
|
Chang, R.M., et al. (2016) MicroRNA-130b Promotes Proliferation and EMT-Induced Metastasis via PTEN/p-AKT/HIF-1α Signaling. Tumor Biology, 37, 10609-10619. https://doi.org/10.1007/s13277-016-4919-z
|
[39]
|
Lin, J., et al. (2018) Long Non-Coding RNA UBE2CP3 Enhances HCC Cell Secretion of VEGFA and Promotes Angiogenesis by Activating ERK1/2/HIF-1α/VEGFA Signalling in Hepatocellular Carcinoma. Journal of Experimental & Clinical Cancer Research, 37, 113. https://doi.org/10.1186/s13046-018-0727-1
|
[40]
|
Sun, T., et al. (2010) Expression and Functional Significance of Twist1 in Hepatocellular Carcinoma: Its Role in Vasculogenic Mimicry. Hepatology, 51, 545-556. https://doi.org/10.1002/hep.23311
|
[41]
|
Wang, L., et al. (2015) Metastasis-Associated in Colon Cancer-1 Promotes Vasculogenic Mimicry in Gastric Cancer by Upregulating TWIST1/2. Oncotarget, 6, 11492-11506. https://doi.org/10.18632/oncotarget.3416
|
[42]
|
Chaw, S.Y., et al. (2012) Epithelial to Mesenchymal Transition (EMT) Biomarkers—E-Cadherin, Beta-Catenin, APC and Vimentin—in Oral Squamous Cell Carcinogenesis and Transformation. Oral Oncology, 48, 997-1006.
https://doi.org/10.1016/j.oraloncology.2012.05.011
|
[43]
|
Xu, Y., et al. (2012) Short-Term Anti-Vascular Endothelial Growth Factor Treatment Elicits Vasculogenic Mimicry Formation of Tumors to Accelerate Metastasis. Journal of Experimental & Clinical Cancer Research, 31, 16.
https://doi.org/10.1186/PREACCEPT-1800076486556870
|
[44]
|
Wang, M., et al. (2017) HIF-1α Promoted Vasculogenic Mimicry Formation in Hepatocellular Carcinoma through LOXL2 Up-Regulation in Hypoxic Tumor Microenvironment. Journal of Experimental & Clinical Cancer Research, 36, 60. https://doi.org/10.1186/s13046-017-0533-1
|
[45]
|
Yang, J., et al. (2017) HIF-2α Promotes the Formation of Vasculogenic Mimicry in Pancreatic Cancer by Regulating the Binding of Twist1 to the VE-cadherin Promoter. Oncotarget, 8, 47801-47815.
https://doi.org/10.18632/oncotarget.17999
|
[46]
|
Jiang, B. (2017) Aerobic Glycolysis and High Level of Lactate in Cancer Metabolism and Microenvironment. Genes and Diseases, 4, 25-27. https://doi.org/10.1016/j.gendis.2017.02.003
|
[47]
|
Chiche, J., Brahimi-Horn, M.C. and Pouysségur, J. (2010) Tumour Hypoxia Induces a Metabolic Shift Causing Acidosis: A Common Feature in Cancer. Journal of Cellular and Molecular Medicine, 14, 771-794.
https://doi.org/10.1111/j.1582-4934.2009.00994.x
|
[48]
|
Pouysségur, J., Dayan, F. and Mazure, N.M. (2006) Hypoxia Signalling in Cancer and Approaches to Enforce Tumour Regression. Nature, 441, 437-443. https://doi.org/10.1038/nature04871
|
[49]
|
Semenza, G.L. (2003) Targeting HIF-1 for Cancer Therapy. Nature Reviews Cancer, 3, 721-732.
https://doi.org/10.1038/nrc1187
|
[50]
|
Li, X.F., et al. (2007) Visualization of Hypoxia in Microscopic Tumors by Immunofluorescent Microscopy. Cancer Research, 67, 7646-7653. https://doi.org/10.1158/0008-5472.CAN-06-4353
|
[51]
|
Li, X.F. and O’Donoghue, J.A. (2008) Hypoxia in Microscopic Tumors. Cancer Letters, 264, 172-180.
https://doi.org/10.1016/j.canlet.2008.02.037
|
[52]
|
Cao, Y., et al. (2005) Observation of Incipient Tumor Angiogenesis That Is Independent of Hypoxia and Hypoxia Inducible Factor-1 Activation. Cancer Research, 65, 5498-5505. https://doi.org/10.1158/0008-5472.CAN-04-4553
|
[53]
|
Yakata, Y., et al. (2007) Expression of p-STAT3 in Human Gastric Carcinoma: Significant Correlation in Tumour Invasion and Prognosis. International Journal of Oncology, 30, 437-442.
|
[54]
|
Song, Y.Y., et al. (2014) STAT3, p-STAT3 and HIF-1α Are Associated with Vasculogenic Mimicry and Impact on Survival in Gastric Adenocarcinoma. Oncology Letters, 8, 431-437. https://doi.org/10.3892/ol.2014.2059
|
[55]
|
Xu, Q., et al. (2005) Targeting Stat3 Blocks both HIF-1 and VEGF Expression Induced by Multiple Oncogenic Growth Signaling Pathways. Oncogene, 24, 5552-5560. https://doi.org/10.1038/sj.onc.1208719
|
[56]
|
Li, S., Meng, W., Guan, Z.W., Guo, Y.L. and Han, X.Z. (2016) The Hypoxia-Related Signaling Pathways of Vasculogenic Mimicry in Tumor Treatment. Biomedicine & Pharmacotherapy, 80, 127-135.
https://doi.org/10.1016/j.biopha.2016.03.010
|
[57]
|
Zhang, J.G., et al. (2020) Hypoxic Induction of Vasculogenic Mimicry in Hepatocellular Carcinoma: Role of HIF-1 α, RhoA/ROCK and Rac1/PAK Signaling. BMC Cancer, 20, Article No. 32. https://doi.org/10.1186/s12885-019-6501-8
|
[58]
|
Fernández-Barral, A., et al. (2012) Hypoxia Negatively Regulates Antimetastatic PEDF in Melanoma Cells by a Hypoxia Inducible Factor-Independent, Autophagy Dependent Mechanism. PLoS ONE, 7, e32989.
https://doi.org/10.1371/journal.pone.0032989
|
[59]
|
Gustafsson, M.V., et al. (2005) Hypoxia Requires Notch Signaling to Maintain the Undifferentiated Cell State. Developmental Cell, 9, 617-628. https://doi.org/10.1016/j.devcel.2005.09.010
|
[60]
|
Quail, D.F., et al. (2011) Low Oxygen Levels Induce the Expression of the Embryonic Morphogen Nodal. Molecular Biology of the Cell, 22, 4809-4821. https://doi.org/10.1091/mbc.e11-03-0263
|
[61]
|
Li, W., Zong, S.Q., Shi, Q., Li, H.J., Xu, J. and Hou, F.G. (2016) Hypoxia-Induced Vasculogenic Mimicry Formation in Human Colorectal Cancer Cells: Involvement of HIF-1a, Claudin-4, and E-Cadherin and Vimentin. Scientific Reports, 6, Article No. 37534. https://doi.org/10.1038/srep37534
|
[62]
|
Sun, J., et al. (2000) Contributions of the Extracellular and Cytoplasmic Domains of Platelet-Endothelial Cell Adhesion Molecule-1 (PECAM-1/CD31) in Regulating Cell-Cell Localization. Journal of Cell Science, 113, 1459-1469.
https://doi.org/10.1242/jcs.113.8.1459
|
[63]
|
Newman, D.K., et al. (2002) Nitration of PECAM-1 ITIM Tyrosines Abrogates Phosphorylation and SHP-2 Binding. Biochemical and Biophysical Research Communications, 296, 1171-1179.
https://doi.org/10.1016/S0006-291X(02)02060-0
|
[64]
|
Righi, L., et al. (2003) Role of CD31/Platelet Endothelial Cell Adhesion Molecule-1 Expression in in Vitro and in Vivo Growth and Differentiation of Human Breast Cancer Cells. The American Journal of Pathology, 162, 1163-1174.
https://doi.org/10.1016/S0002-9440(10)63912-0
|
[65]
|
Sapino, A., et al. (2001) Expression of CD31 by Cells of Extensive Ductal in Situ and Invasive Carcinomas of the Breast. The Journal of Pathology, 194, 254-261.
https://doi.org/10.1002/1096-9896(200106)194:2<254::AID-PATH880>3.0.CO;2-2
|
[66]
|
Stacchini, A., et al. (2003) Expression of the CD31 Antigen in Normal B-Cells and Non Hodgkin’s Lymphomas. Journal of Biological Regulators and Homeostatic Agents, 17, 308-315.
|
[67]
|
Goldberger, A., Middleton, K.A. and Newman, P.J. (1994) Changes in Expression of the Cell Adhesion Molecule PECAM-1 (CD31) during Differentiation of Human Leukemic Cell Lines. Tissue Antigen, 44, 285-293.
https://doi.org/10.1111/j.1399-0039.1994.tb02397.x
|
[68]
|
Tang, D.G., et al. (1993) Identification of PECAM-1 in Solid Tumor Cells and Its Potential Involvement in Tumor Cell Adhesion to Endothelium. Journal of Biological Chemistry, 268, 22883-22894.
https://doi.org/10.1016/S0021-9258(18)41609-2
|
[69]
|
Handra-Luca, A. (2019) CD31 Immunohistochemical Expression in Tumors. Applied Immunohistochemistry & Molecular Morphology, 27, e98-e99. https://doi.org/10.1097/PAI.0000000000000693
|
[70]
|
Newman, P.J. and Newman, D.K. (2003) Signal Transduction Pathways Mediated by PECAM-1: New Roles for an Old Molecule in Platelet and Vascular Cell Biology. Arteriosclerosis, Thrombosis, and Vascular Biology, 23, 953-964.
https://doi.org/10.1161/01.ATV.0000071347.69358.D9
|
[71]
|
Ilan, N. and Madri, J.A. (2003) PECAM-1: Old Friend, New Partners. Current Opinion in Cell Biology, 15, 515-524.
https://doi.org/10.1016/S0955-0674(03)00100-5
|
[72]
|
Jackson, D.E. (2003) The Unfolding Tale of PECAM-1. FEBS Letters, 540, 7-14.
https://doi.org/10.1016/S0014-5793(03)00224-2
|
[73]
|
Abraham, V., et al. (2018) Involvement of TIMP-1 in PECAM-1-Mediated Tumor Dissemination. International Journal of Oncology, 53, 488-502. https://doi.org/10.3892/ijo.2018.4422
|
[74]
|
Zhang, Y.Y., et al. (2018) CD31 Regulates Metastasis by Inducing Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma via the ITGB1-FAK-Akt Signaling Pathway. Cancer Letters, 429, 29-40.
https://doi.org/10.1016/j.canlet.2018.05.004
|
[75]
|
Musumeci, G., et al. (2015) Enhanced Expression of CD31/Platelet Endothelial Cell Adhesion Molecule 1 (PECAM1) Correlates with Hypoxia Inducible Factor-1 Alpha (HIF-1α) in Human Glioblastoma Multiforme. Experimental Cell Research, 339, 407-416. https://doi.org/10.1016/j.yexcr.2015.09.007
|